92 related articles for article (PubMed ID: 2171727)
1. [Protective effect of a platelet activating factor antagonist in experimental liver injury].
Zhang F
Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):375-8, 26. PubMed ID: 2171727
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
Casals-Stenzel J
Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490
[TBL] [Abstract][Full Text] [Related]
3. [The roles of platelet activating factor in intestinal mucosal barrier injury after burn].
Yu P; Xiao G; Fu W
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):393-5. PubMed ID: 8565724
[TBL] [Abstract][Full Text] [Related]
4. Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury.
Komatsu Y; Shiratori Y; Hikiba Y; Hashimoto N; Han K; Kawase T; Yoshida H; Okano K; Omata M
Dig Dis Sci; 1996 May; 41(5):1030-7. PubMed ID: 8625746
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury.
Chang SW; Fernyak S; Voelkel NF
Am J Physiol; 1990 Jan; 258(1 Pt 2):H153-8. PubMed ID: 2301603
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G
J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
Stahl GL; Bitterman H; Lefer AM
Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
Da Costa M; Metcalfe S; Calne RY
Transplant Proc; 1990 Aug; 22(4):1945-6. PubMed ID: 2389490
[No Abstract] [Full Text] [Related]
11. Modulation of hepatotoxicity by macrophages in the liver.
Shiratori Y; Kawase T; Shiina S; Okano K; Sugimoto T; Teraoka H; Matano S; Matsumoto K; Kamii K
Hepatology; 1988; 8(4):815-21. PubMed ID: 2839405
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
Libert C; Van Molle W; Brouckaert P; Fiers W
J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
[TBL] [Abstract][Full Text] [Related]
13. BN-50739: a PAF antagonist and limitation of myocardial infarct size.
Ranaut K; Singh M
Methods Find Exp Clin Pharmacol; 1993; 15(1):9-14. PubMed ID: 8479250
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
Heuer H; Casals-Stenzel J
Prog Clin Biol Res; 1989; 308():925-30. PubMed ID: 2675077
[No Abstract] [Full Text] [Related]
15. Platelet-activating factor antagonists in experimental shock.
Muacevic G; Heuer HO
Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
[TBL] [Abstract][Full Text] [Related]
16. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
Heuer H
Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
[No Abstract] [Full Text] [Related]
17. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
Bouvier C; Guc MO; Furman BL; Parratt JR
Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
